Safety and efficacy of agomelatine in children and adolescents with major depressive disorder receiving psychosocial counselling: a double-blind, randomised, controlled, phase 3 trial in nine countries
Year: 2021
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: The Lancet Psychiatry
Authors: Celso Arango, Jan K Buitelaar, Jörg M Fegert, Valérie Olivier, Pierre-François Pénélaud, Ute Marx, Damien Chimits, Bruno Falissard, Julia Barylnik, Laura Birdeanu, Gert P Bosch, Julia Boychevskaya, Igor Boyev, Enikõ Bugán, Olga Bukhanovskaya, Oleg Chaban, Iuliana Dobrescu, Gábor Feller, Halina Flisiak-Antonijczuk, Magdolna Gácser, Elena Grigorieva, Timo Holttinen, Svetlana Ivanovic-Kovacevic, Krisztina Kapornai, Lala Kasimova, Evgeniy Koren, Igor Martsenkovsky, Nataliya O Maruta, Mirela Matican, Tetiana Matkovska, Ellina Melnyk, Milica Pejovic Milovancevic, Olha Mostova, Peter Nagy, Laura Nussbaum, Petar Petrov, Bozena Pietraszczyk-Kedziora, Nadia Polnareva, Elena Predescu, Vladislava Razsolkova, Filip Rybakowski, Sofiia Rymsha, Juan P Schrönen, Dmitrii Shigashov, Andrii Skrypnikov, Miodrag Stankovic, Dejan Stevanovic, Markku Timonen, Juha-Matti Väänänen, Jannie van der Westhuizen, Gert van Niekerk, Olena Venger, Anatolii Voloshchuk, Tomasz Wolañczyk
Institutions: Hospital General Universitario Gregorio Marañón, Centro de Investigación Biomédica en Red de Salud Mental, Radboud University Nijmegen, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, University Hospital Ulm, Institut de Recherches Internationales Servier (France), Servier (Germany), Inserm, Centre de recherche en Epidémiologie et Santé des Populations, Santé mentale et santé publique
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4200283204